Skip to main content

Table 1 Demographic and clinical characteristics of patients with MSA-P, PD 2–5 years duration and healthy controls

From: A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy

 

MSA-P

PD 2–5 years

Healthy controls

p

N

30

10

10

DEMOGRAPHIC AND CLINICAL CHARACTERISTICS

Sex – males (%)

12 (40%)

8 (80%)

6 (60%)

0.077

Age at MRI (years)

66.8 ± 8.4

66.9 ± 6,1

61.4 ± 7.0

0.161

MSA 2nd consensus criteria

 

NA

NA

NA

- Possible MSA

22 (73%)

- Probable MSA

8 (27%)

Time from 1st symptom at MRI, mean ± SD/median (years)

4.6 ± 2.7 /4

(2 missing values)

NA

NA

NA

Time from diagnosis at MRI, mean ± SD /median (years)

2.4 ± 2.7 /1.2

(2 missing values)

NA

NA

NA

Presenting symptom

 

NA

NA

NA

- motor-parkinsonism

23/28 (82%)

- dysautonomia

4/28 (14%)

- other

1/28 (4%)

(2 missing values)

Presence of cerebellar signs

8/27 (30%)

(3 missing values)

NA

NA

 

Hoehn & Yahr stage at MRI, mean/median

2.5 ± 0.5/2

(5 missing values)

2,0 ± 0,0/2

(2 missing values)

NA

< 0.001

LEDD at MRI (mg/day)

674 ± 483

(4 missing values)

562 ± 279

(1 missing values)

NA

0.527

  1. Bold values mean significant statistical differences
  2. Abbreviations: MSA-P: Multiple system atrophy parkinsonian variant, PD Parkinson disease, MRI Magnetic resonance imaging, NA Not applicable, SD Standard Deviation, LEDD Levodopa equivalent daily dose